Apremilast and Retinitis - a phase IV clinical study of FDA data

Summary:

Retinitis is reported as a side effect among people who take Apremilast (apremilast), especially for people who are female, 40-49 old, also take Prednisone, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Retinitis when taking Apremilast. It is created by eHealthMe based on reports of 4,162 people who have side effects when taking Apremilast from the FDA, and is updated regularly.

What is Apremilast?

Apremilast has active ingredients of apremilast. eHealthMe is studying from 4,162 Apremilast users. Check the latest studies of Apremilast.

What is Retinitis?

Retinitis (inflammation of the retina in the eye) is found to be associated with 228 drugs and 203 conditions by eHealthMe. Check the latest studies of Retinitis.

On Jul, 20, 2026

4,162 people reported to have side effects when taking Apremilast.
Among them, 47 people (1.13%) have Retinitis.

Among these 47 people:

What is the gender of people who have Retinitis when taking Apremilast? *

female: 100 %
male: 0.0 %

What is the age of people who have Retinitis when taking Apremilast? *

What are other drugs people take besides Apremilast? *

What are other side effects people have besides Retinitis? *

Pneumonia: 45 people, 95.74%
Red Blood Cell Sedimentation Rate Increased: 44 people, 93.62%
Osteoporosis (bones weak and more likely to break): 43 people, 91.49%
Visual Impairment: 43 people, 91.49%
Joint Dislocation (a joint position is changed from normal position): 40 people, 85.11%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 40 people, 85.11%
Foot Deformity (functional disability of foot): 40 people, 85.11%
Nausea (feeling of having an urge to vomit): 40 people, 85.11%
Oedema Peripheral (superficial swelling): 39 people, 82.98%
Lupus-Like Syndrome (a disease symptom matches with lupus an immune disease): 39 people, 82.98%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 38 people, 80.85%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 31 people, 65.96%
Psoriasis (immune-mediated disease that affects the skin): 21 people, 44.68%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 21 people, 44.68%
Pain: 15 people, 31.91%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 15 people, 31.91%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 9 people, 19.15%
Fibromyalgia (a long-term condition which causes pain all over the body): 8 people, 17.02%
Headache (pain in head): 7 people, 14.89%
Ankylosing Spondylitis (type of arthritis affecting the spine): 6 people, 12.77%

* Approximation only. Some reports may have incomplete information.

Do you take Apremilast and have Retinitis?

- Check whether Retinitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Apremilast:

Apremilast (4,162 reports)

Retinitis treatments and more:

Retinitis (1,262 reports)

Browse all side effects of Apremilast:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Retinitis:

Retinitis (228 drugs)

Browse all the conditions that are associated with Retinitis:

Retinitis (203 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on apremilast (the active ingredients of Apremilast) and Apremilast (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.